FDA approves new nasal spray to treat potentially life-threatening allergic reactions
On Friday, the FDA approved Neffy, the first nasal spray to be used as an emergency treatment for the tens of millions of Americans at risk of potentially life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know about the new needle-free alternative to the EpiPen.